178 No author list (2023)
This appears largely due to the ability of GIPR agonism to suppress the nausea caused by GLP1R agonism
The medications in this class include semaglutide, sold as Ozempic for diabetes and Wegovy for weight loss, and tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management
adults are taking GLP-1 medications such as semaglutide and tirzepatide, up from 14% in 2025
Whilst nausea doesn't directly cause increased bowel movements, it may influence dietary choices that subsequently affect stool patterns
Supports toxin elimination, nutrient absorption, brain, cardiovascular health, immunity, energy, antioxidant, reduces liver processing burden